In patients with moderately severe to very severe NPDR at baseline, RBX did not prevent retinopathy progression to proliferative disease. However, compared with placebo, treatment with 32 mg/day ...
Lasers are being improved, for example, the use of subthreshold diode micropulse (SDM) effectively treats severe NPDR and PDR without causing laser-induced retinal damage and the complications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback